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IK is a 10-year-old HIV non-reactive boy who was referred 
to Queen Elizabeth Central Hospital (QECH) General 
Paediatric Clinic in early October 2007 with complaints of  
several months of  multiple joint swellings and loss of  range 
of  movement.  We could not identify any obvious trigger 
for the joint problems.  There were no associated systemic 
features such as fever, lethargy, malaise or rash.  
He was a thin, rather despondent looking child with tender, 
boggy, non-erythematous but mildly warm swelling of  both 
ankles (figure 1), knees (figure 2), elbows and wrists as well 
as several proximal interphalangeal (PIP) joints bilaterally 
(figure 3).  All of  these joints were tender and had a reduced 
range of  movement, and he found it difficult and painful to 
walk.  There was no rash or fever, no obvious eye changes, 
no lymphadenopathy and a normal abdominal examination. 
He had been managed at a nearby hospital for the previous 
month with prednisolone 5mg twice daily and regular 
ibuprofen (200mg tds) for a presumed inflammatory process, 
as well as flucloxacillin for a potential infective component. 
There had not been much change in his symptoms over this 
time.
IK’s family, including his parents, two brothers and a sister, all 
live in Nsanje where his father works as a computer software 
installer.  The other family members were all well and IK 
himself  had not suffered from any other significant medical 
conditions in the past.
What is the likely diagnosis?
What management steps would you institute?
What would be your further management if his 
initial response was poor?
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Figure 1 swelling of both ankles 
Figure 2 swelling of the knees
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X-rays showed evidence of  osteomyelitis involving almost 
Case discussion of  patient IK
We made a presumptive diagnosis of  polyarticular juvenile 
idiopathic arthritis (JIA).  
The child was commenced on a higher-dose course of  
prednisolone 20mg daily for 2 weeks, then reduced to 10mg 
& 5mg for a further 2 weeks each.  Ibuprofen was continued, 
and we added a proton pump inhibitor to reduce excessive 
gastric acid secretion that might result from  the other 
drugs.  He was also sent for ophthalmological assessment 
for potential uveitis (although this is more common in 
oligoarticular JIA) and commenced on some supplementary 
feeds.
Upon review one month later IK was much improved, with 
a pain-free gait and significant reduction in the inflammation 
of  his involved joints.  He was much happier in himself  
and was putting on weight (although this may have been a 
side effect of  the steroid therapy as much as the nutritional 
supplementation).  He was maintained on low dose 
prednisolone (5mg per day) orally as well as his non-steroidal 
anti-inflammatory drug (NSAID).
Over the next several months IK had a stormy course of  
recurrent symptom flare-ups requiring higher dosing of  
prednisolone for their control.  He was never able to do 
without treatment altogether. We considered the possibility 
of  giving steroids directly by intra-articular injection, but 
this was not a realistic option since so many joints were 
affected.  
We discussed the option of  adding a disease modifying anti-
rheumatoid drug (DMARD), methotrexate, to his treatment, 
and were planning to commence this when IK again presented 
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with signs of  a severe flare-up involving both knees, both 
ankles and several tarsal bones, his right elbow and several 
PIP joints.  He was now almost unable to bear weight.   We 
administered high dose IV pulse steroids, using 1g/m2 
dexamethasone on days 1, 3 & 5.  He responded well to this 
and we then recommenced daily high dose oral steroids, to 
which we added methotrexate 10mg/m2 once weekly.  A full 
blood count was normal prior to commencing the DMARD. 
We added folic acid to the regimen because methotrexate is 
a dihydrofolate reductase inhibitor.
After a one month admission with intensive physiotherapy 
he had improved but was still having great difficulty walking. 
Before discharge he was given a single slow IV dose of  
15mg/m2 methotrexate with normal saline hyperhydration 
and cotrimoxazole prophylaxis, then sent home with an 
increased dose of  20mg/m2/week methotrexate, tapering 
prednisolone dosing, a proton pump inhibitor, a NSAID 
and folic acid.  He had become somewhat Cushingoid in 
appearance by this time.  
IK’s father has been told that the methotrexate is ‘disease 
modifying’, and therefore that it will take several months to 
convey its full benefit.  He is to be seen weekly in Nsanje, 
and will travel to the central hospital in Blantyre ~2-monthly 
where his symptoms and full blood count will be reviewed.
If  funds were available, this boy would be an excellent 
candidate for early introduction of  a biologic disease-
modifying agent (e.g. etanercept, a drug that contains a 
TNF-binding receptor which modifies TNF’s inflammatory 
effects).  Even if  it could be afforded, such therapy would 
only be considered if  his response to methotrexate were to 
prove unsatisfactory in the coming months.
